↓ Skip to main content

Dove Medical Press

Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis

Overview of attention for article published in Therapeutics and Clinical Risk Management, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
2 Mendeley
Title
Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis
Published in
Therapeutics and Clinical Risk Management, March 2022
DOI 10.2147/tcrm.s351317
Pubmed ID
Authors

Yi-Ran Han, Tian-Hao Wang, Wen-Ping Gong, Jian-Qin Liang, Hui-Ru An

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 100%
Professor 1 50%
Readers by discipline Count As %
Agricultural and Biological Sciences 1 50%
Neuroscience 1 50%
Medicine and Dentistry 1 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2022.
All research outputs
#4,840,893
of 25,392,582 outputs
Outputs from Therapeutics and Clinical Risk Management
#230
of 1,323 outputs
Outputs of similar age
#107,855
of 449,877 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 23 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,877 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.